nancy lynn MD snyderman

ALKS

nancy lynn MD snyderman serves as Director at Alkermes plc (ALKS). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$10.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$10.0K

Companies Traded

ALKS

Active Period

Mar 2022

1 total trades

Most Recent

Buy ALKS

Mar 4, 2022 · $10.0K

nancy lynn MD snyderman's Insider Trading at Alkermes plc (ALKS)

Buys

1 · $10.0K

Sells

0 · $0.00

Total Shares Bought

427

Total Shares Sold

ALKS Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Mar 4, 2022	Buy	427	$23.43	$10.0K	0

Related Insiders

David Joseph Gaffin

EVP, CLO, Alkermes, Inc.

ALKSSell · Feb 18, 2026

Craig C. Hopkinson

EVP R&D, Chief Medical Officer

ALKSSell · Feb 18, 2026

Blair Curtis Jackson

EVP, Chief Operating Officer

ALKSSell · Feb 18, 2026

Christian Todd Nichols

SVP, Chief Commercial Officer

ALKSSell · Feb 18, 2026

Samuel Joseph Parisi

VP, Finance (Interim PAO)

ALKSSell · Feb 18, 2026

POPS RICHARD F

Director and CEO, Alkermes plc

ALKSSell · Feb 5, 2026

Shane Cooke

Director

ALKSSell · Feb 2, 2026

Christopher I Wright

Director

ALKSSell · Jun 8, 2025

Explore More Insider Trading Data

ALKS Insider Trading Activity

View all insider trades at Alkermes plc

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity